Strategic Grants for Outstanding Women
Associate Professor Kimberley Haines, Dr Yasmine Ali Abdelhamid and Dr Emily See have all been awarded Strategic Grants for Outstanding Women from the Melbourne Medical School.
The grants are highly competitive and the recipients represent a diverse and talented field of women researchers, clinicians and educators who have made significant impact in their speciality area.
The grants create an opportunity for recipients to build connections and visibility in line with their research, clinical and teaching goals.
We are thrilled to have three of the fourteen awardees from our department - testament to the excellent research culture fostered in critical care and the amazing work of these women.
Dr Yasmine Ali Abdelhamid is an intensive care specialist and clinician-scientist. Her postdoctoral work focuses on improving long-term outcomes for survivors of critical illness. She is passionate about fostering the next generation of medical researchers and holds key leadership roles in the Australian and New Zealand Intensive Care Society and its Clinical Trials group, as well as the University. This grant will allow Dr Abdelhamid to progress her research program and build her team, dedicate additional time to student supervision and mentoring, while building international connections and pursuing important leadership roles.
Associate Professor Kimberley Haines is a mid-career researcher and Clinical Associate Professor/Principal Research Fellow in the Department of Critical Care. Associate Professor Haines is the Physiotherapy Research Lead at Western Health, and is undertaking her NHMRC Investigator Grant EL1 in co-designed ICU recovery.
Associate Professor Haines is an emerging national and international leader in the field of critical care survivorship, and is a preeminent leader in consumer engagement and co-design. This grant will support Associate Professor Haines to build out her research program in this area, and build research capacity by developing the next generation of researchers at the University of Melbourne.
Dr Emily See is an Intensivist and Nephrologist at the Royal Melbourne Hospital and a Senior Honorary Fellow in the Department of Critical Care at the University of Melbourne. Her clinical and research interests centre around acute kidney injury, continuous renal replacement therapy, and the management of vasodilatory shock.
This grant will allow Dr See to undertake pivotal work investigating the safety and efficacy of angiotensin II in the management of critically ill patients with vasodilatory shock. The findings of this research program have the potential to fundamentally change the way vasodilatory shock is managed on a global scale, while focusing on impacting the outcomes prioritised by patients, caregivers, and clinicians.